388 related articles for article (PubMed ID: 24509452)
21. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
[TBL] [Abstract][Full Text] [Related]
22. Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response.
Shwaartz C; Haim N; Rosin D; Lawrence Y; Gutman M; Zmora O
Colorectal Dis; 2015 Jul; 17(7):595-9. PubMed ID: 25605475
[TBL] [Abstract][Full Text] [Related]
23. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Daniel ES; Gibbs P; Guerrieri M; Faragher I
Colorectal Dis; 2014 Oct; 16(10):783-7. PubMed ID: 24786681
[TBL] [Abstract][Full Text] [Related]
24. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
Yu SK; Tait D; Chau I; Brown G
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
[TBL] [Abstract][Full Text] [Related]
25. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
26. Tumor scatter after neoadjuvant therapy for rectal cancer: are we dealing with an invisible margin?
Hayden DM; Jakate S; Pinzon MC; Giusto D; Francescatti AB; Brand MI; Saclarides TJ
Dis Colon Rectum; 2012 Dec; 55(12):1206-12. PubMed ID: 23135577
[TBL] [Abstract][Full Text] [Related]
27. Complete Pathological Response After Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer and Its Relationship to the Degree of T3 Mesorectal Invasion.
Wilkins S; Haydon A; Porter I; Oliva K; Staples M; Carne P; McMurrick P; Bell S
Dis Colon Rectum; 2016 May; 59(5):361-8. PubMed ID: 27050597
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.
Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Morikawa T; Fukayama M; Watanabe T
Dis Colon Rectum; 2017 Apr; 60(4):368-375. PubMed ID: 28267003
[TBL] [Abstract][Full Text] [Related]
29. Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT.
Perez RO; Habr-Gama A; Smith FM; Kosinski L; São Julião GP; Grzona E; Rawet V; Vianna MR; Proscurshim I; Lynn PB; Gama-Rodrigues J
J Surg Oncol; 2014 Jun; 109(8):853-8. PubMed ID: 24862927
[TBL] [Abstract][Full Text] [Related]
30. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
[TBL] [Abstract][Full Text] [Related]
31. MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Franklin JM; Anderson EM; Gleeson FV
Clin Radiol; 2012 Jun; 67(6):546-52. PubMed ID: 22218409
[TBL] [Abstract][Full Text] [Related]
32. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
33. Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.
Liu S; Zhong GX; Zhou WX; Xue HD; Pan WD; Xu L; Lu JY; Wu B; Lin GL; Qiu HZ; Xiao Y
Dis Colon Rectum; 2018 Aug; 61(8):903-910. PubMed ID: 29944579
[TBL] [Abstract][Full Text] [Related]
34. Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?
Tulchinsky H; Rabau M; Shacham-Shemueli E; Goldman G; Geva R; Inbar M; Klausner JM; Figer A
Ann Surg Oncol; 2006 Mar; 13(3):347-52. PubMed ID: 16450221
[TBL] [Abstract][Full Text] [Related]
35. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
[TBL] [Abstract][Full Text] [Related]
36. Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.
Tsang JS; Vencken S; Sharaf O; Leen E; Kay EW; McNamara DA; Deasy J; Mulligan ED
Eur J Surg Oncol; 2014 Nov; 40(11):1459-66. PubMed ID: 25108814
[TBL] [Abstract][Full Text] [Related]
37. Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?
Smith FM; Ahad A; Perez RO; Marks J; Bujko K; Heald RJ
Dis Colon Rectum; 2017 Feb; 60(2):228-239. PubMed ID: 28059920
[TBL] [Abstract][Full Text] [Related]
38. Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation: implications for treatment decisions.
Smith FM; Wiland H; Mace A; Pai RK; Kalady MF
Colorectal Dis; 2014 Aug; 16(8):610-5. PubMed ID: 24593015
[TBL] [Abstract][Full Text] [Related]
39. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
40. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
